Dec. 07. 2023
Osaka, Japan – December 7, 2023 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Motohiko Kimura) today announced the listing of a single generic drug with two strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 332 compounds with 806 strengths.
The list of new products
1. Lenalidomide Capsules
| Generic name | Lenalidomide |
|---|---|
| Strengths | 2.5mg, 5mg |
| Brand products | Revlimid® Capsules 2.5mg, 5mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.